Characterizing the Course of SARS-CoV-2 on Cardiac Arrhythmias

164672-Thumbnail Image.png
Description

This thesis is a retrospective study analyzing data from patient implanted cardiac devices in other to determine the effect of SARS-CoV-2 on cardiac arrhythmias. This study is also the first, to the knowledge of the researchers, in which a cohort

This thesis is a retrospective study analyzing data from patient implanted cardiac devices in other to determine the effect of SARS-CoV-2 on cardiac arrhythmias. This study is also the first, to the knowledge of the researchers, in which a cohort of undifferentiated hospitalized and non-hospitalized COVID patients were studied using data from cardiac implanted devices. The results from this study has shown that SARS-CoV-2 leads to statistically significant increases in arrhythmic burden, in particular increased overall arrhythmic episodes, increased VT episodes, increased AT Burden percent, and increased SVT Average Ventricular Rate, and a statistically significant decrease in VT Average Ventricular Rate.

Date Created
2022-05
Agent

Characterizing the Course of SARS-CoV-2 on Cardiac Arrhythmias

164671-Thumbnail Image.png
Description
This thesis is a retrospective study analyzing data from patient implanted cardiac devices in order to determine the effect of SARS-CoV-2 on cardiac arrhythmias. This study is also the first, to the knowledge of the researchers, in which a cohort

This thesis is a retrospective study analyzing data from patient implanted cardiac devices in order to determine the effect of SARS-CoV-2 on cardiac arrhythmias. This study is also the first, to the knowledge of the researchers, in which a cohort of undifferentiated hospitalized and non-hospitalized COVID patients were studied using data from cardiac implanted devices. The results from this study has shown that SARS-CoV-2 leads to statistically significant increases in arrhythmic burden, in particular increased overall arrhythmic episodes, increased VT episodes, increased AT Burden percent, and increased SVT Average Ventricular Rate, and a statistically significant decrease in VT Average Ventricular Rate.
Date Created
2022-05
Agent